|
|
 |
LAURAMINE OXIDE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
LECITHIN, SOYBEAN Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
LANOLIN ALCOHOLS Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
LUTATHERA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|